News

  • Wrist cooling could help managing hot flash study finds

    A cooling wristband device was found to reduce severe hot flash episodes by 46 per cent in breast cancer patients, prostate cancer patients and postmenopausal women, new research has shown. The device reduced severe episodes by 41 per cent in breast cancer patients and 50 per cent in prostate cancer patients and postmenopausal women. It [...]

  • Tens of thousands demand menstrual leave to be written into UK law

    More than 65,000 people have signed a petition for menstrual leave to be added to UK employment rights law. The campaign needs 100,000 signatures for a parliamentary debate. It was launched by Scots mum Michelle Dewar, who endured chronic pain for nine years before being diagnosed with endometriosis – a condition where tissue similar to [...]

  • Long covid linked to longer, heavier periods

    Women with long Covid reported abnormal bleeding around their menstrual cycles, according to new research involving more than 12,000 women in the UK. The study found periods were often longer and heavier, with bleeding between cycles. Symptoms also fluctuated across the menstrual cycle, worsening in the days before menstruation and during the proliferative phase – [...]

  • UK’s first Pink Duck Race raises thousands for breast cancer

    The UK’s first pink duck race has raised thousands for breast cancer support after 5,000 rubber ducks floated down Cambridge’s River Cam. Each duck represented a £5 donation to Pink Ribbon Foundation, with participants competing for a nine carat rose gold necklace encrusted with 48 diamonds, shaped like a rubber duck. The winning duck was [...]

  • Hospitals roll out gene testing for newborns in national study

    UK hospitals have started testing newborns for more than 200 rare genetic conditions in what researchers call a landmark national study. Forty-seven NHS hospitals, including Sunderland Royal Hospital, South Tyneside District Hospital and Newcastle’s Royal Victoria Infirmary, are taking part in the Generation Study. The aim is to test 100,000 babies, with the study set [...]

  • Starting menopause therapy early may lower Alzheimer’s risk, study finds

    Starting hormone therapy within five years of menopause could lower women’s Alzheimer’s risk by up to 32 per cent, but beginning at 65 or later may raise it, research shows. The analysis pooled findings from more than 50 studies comparing women who used hormone replacement therapy (HRT) to those who did not. Researchers from the [...]

  • Endometriosis linked to hundreds of conditions across the body, study finds

    Analysis of millions of health records shows endometriosis is connected to more than 600 conditions, including migraines, asthma and digestive disorders. The research used algorithms to compare medical histories of people with and without endometriosis, confirming known associations and revealing new ones. Scientists at the University of California, San Francisco examined data from the University [...]

  • IVF innovation: What you need to know about global regulatory pathways in 2025

    By Juan A. Jiménez, founder and CEO, FindDBest IVF In the fast-moving world of fertility innovation, building a game-changing medical device or diagnostic is only half the journey. The other half? Getting it approved — and into the hands of those who need it. At FinDBest IVF, we work with IVF and ART (Assisted Reproductive [...]

  • Campaign calls for menopause support in cancer care

    Campaigners are urging menopause support to be included in cancer treatment plans after a survey found 90 per cent of patients were given no guidance. The survey of 1,200 people revealed most had no support for managing menopausal changes triggered by treatment. The research was carried out by Menopause and Cancer, whose founder and CEO [...]

  • Hormone therapy heart-safe for under 60s with menopause symptoms

    Hormone therapy is safe for treating menopause symptoms such as hot flushes and night sweats in women aged 50–59, but should not be started after 70 due to cardiovascular risks, research shows. The study analysed 20 years of data from over 27,000 women aged 50–79 with moderate to severe menopausal symptoms who received either treatment [...]